Pharmaceuticals in Germany

Date: June 30, 2017
Pages: 40
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PD81861100CEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Germany
Pharmaceuticals in Germany

SUMMARY

Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

SYNOPSIS

Essential resource for top-line data and analysis covering the Germany pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

KEY HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
  • The German pharmaceuticals market had total revenues of $35.2bn in 2016, representing a compound annual growth rate (CAGR) of 5% between 2012 and 2016.
  • The German market largely consists of companies which are relatively small compared to the large multinational giants which dominate many markets around the world. There are approximately 669 registered pharmaceutical companies in Germany; around 93% of those producing medicine still employ fewer than 500 staff.
  • Germany has a mature market with high healthcare expenditure and domestic pharmaceutical production but it is the cost-saving government policies that remain the largest barrier to future growth.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts
REASONS TO BUY
  • What was the size of the Germany pharmaceuticals market by value in 2016?
  • What will be the size of the Germany pharmaceuticals market in 2021?
  • What factors are affecting the strength of competition in the Germany pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Germany's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Boehringer Ingelheim GmbH
Novartis AG
F. Hoffmann-La Roche Ltd
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Germany pharmaceuticals market value: $ billion, 2012–16
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: Germany pharmaceuticals market share: % share, by value, 2016
Table 4: Germany pharmaceuticals market value forecast: $ billion, 2016–21
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Boehringer Ingelheim GmbH: key facts
Table 10: Boehringer Ingelheim GmbH: key financials ($)
Table 11: Boehringer Ingelheim GmbH: key financials (€)
Table 12: Boehringer Ingelheim GmbH: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: F. Hoffmann-La Roche Ltd: key facts
Table 17: F. Hoffmann-La Roche Ltd: key financials ($)
Table 18: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 19: F. Hoffmann-La Roche Ltd: key financial ratios
Table 20: Germany size of population (million), 2012–16
Table 21: Germany gdp (constant 2005 prices, $ billion), 2012–16
Table 22: Germany gdp (current prices, $ billion), 2012–16
Table 23: Germany inflation, 2012–16
Table 24: Germany consumer price index (absolute), 2012–16
Table 25: Germany exchange rate, 2012–16

LIST OF FIGURES

Figure 1: Germany pharmaceuticals market value: $ billion, 2012–16
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 3: Germany pharmaceuticals market share: % share, by value, 2016
Figure 4: Germany pharmaceuticals market value forecast: $ billion, 2016–21
Figure 5: Forces driving competition in the pharmaceuticals market in Germany, 2016
Figure 6: Drivers of buyer power in the pharmaceuticals market in Germany, 2016
Figure 7: Drivers of supplier power in the pharmaceuticals market in Germany, 2016
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2016
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2016
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2016
Figure 11: Bayer AG: revenues & profitability
Figure 12: Bayer AG: assets & liabilities
Figure 13: Boehringer Ingelheim GmbH: revenues & profitability
Figure 14: Boehringer Ingelheim GmbH: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities
Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities

COMPANIES MENTIONED

Bayer AG
Boehringer Ingelheim GmbH
Novartis AG
F. Hoffmann-La Roche Ltd
Skip to top


OTC Pharmaceuticals in Germany US$ 350.00 Sep, 2016 · 39 pages

Ask Your Question

Pharmaceuticals in Germany
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: